Editorial
World J Hepatol
16(1):1-11.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.1
Abstract (491)
|
Core Tip (537)
|
Full Article (HTML) (2017)
|
Figures (1-1) (359)
|
Full Article (PDF)-1204K (140)
|
Full Article with Cover (PDF)-11949K (116)
|
Full Article (XML)-236K (80)
|
Audio-1342K (6)
|
Peer-Review Report-230K (81)
|
Answering Reviewers-97K (73)
|
Received: 10/26/2023
|
Revised: 12/04/2023
|
Accepted: 12/28/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (5606)
|
Similar Articles (75)
|
Timeline of Article Publication (1)
|
Authors Evaluation (6)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Hepatol
16(1):12-16.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.12
Abstract (515)
|
Core Tip (560)
|
Full Article (HTML) (1378)
|
Tables (1-1) (437)
|
Full Article (PDF)-358K (122)
|
Full Article with Cover (PDF)-11106K (125)
|
Full Article (XML)-54K (74)
|
Audio-1072K (9)
|
Peer-Review Report-236K (71)
|
Answering Reviewers-62K (66)
|
Received: 11/09/2023
|
Revised: 12/05/2023
|
Accepted: 12/19/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (4612)
|
Similar Articles (19)
|
Timeline of Article Publication (1)
|
Authors Evaluation (7)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Minireviews
Role of fecal microbiota transplant in management of hepatic encephalopathy: Current trends and future directions

World J Hepatol
16(1):17-32.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.17
Abstract (566)
|
Core Tip (470)
|
Full Article (HTML) (4709)
|
Figures (1-2) (383)
|
Tables (1-5) (361)
|
Full Article (PDF)-1655K (215)
|
Full Article with Cover (PDF)-12399K (155)
|
Full Article (XML)-226K (75)
|
Audio-1259K (9)
|
Peer-Review Report-216K (78)
|
Answering Reviewers-145K (75)
|
Received: 09/16/2023
|
Revised: 12/02/2023
|
Accepted: 01/03/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (11)
|
Total Visits (8064)
|
Similar Articles (63)
|
Timeline of Article Publication (0)
|
Authors Evaluation (2)
|
Article Quality Tracking (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Hepatol
16(1):33-40.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.33
Abstract (573)
|
Core Tip (497)
|
Full Article (HTML) (3163)
|
Figures (1-1) (385)
|
Full Article (PDF)-601K (228)
|
Full Article with Cover (PDF)-11346K (93)
|
Full Article (XML)-89K (82)
|
Audio-384K (5)
|
Peer-Review Report-180K (66)
|
Answering Reviewers-74K (71)
|
Received: 10/10/2023
|
Revised: 11/06/2023
|
Accepted: 01/05/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (14)
|
Total Visits (6258)
|
Similar Articles (334)
|
Timeline of Article Publication (3)
|
Authors Evaluation (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Retrospective Cohort Study
Direct-acting antivirals failed to reduce the incidence of hepatocellular carcinoma occurrence in hepatitis C virus associated cirrhosis: A real-world study

World J Hepatol
16(1):41-53.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.41
Abstract (555)
|
Core Tip (496)
|
Article Highlights (527)
|
Full Article (HTML) (2022)
|
Figures (1-4) (351)
|
Tables (1-3) (342)
|
Full Article (PDF)-1672K (125)
|
Full Article with Cover (PDF)-12418K (121)
|
Full Article (XML)-173K (73)
|
Audio-467K (6)
|
Peer-Review Report-182K (64)
|
Answering Reviewers-71K (95)
|
Received: 11/21/2023
|
Revised: 12/18/2023
|
Accepted: 01/09/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (6239)
|
Similar Articles (1994)
|
Timeline of Article Publication (2)
|
Authors Evaluation (6)
|
Article Quality Tracking (0)
|
Reader Comments (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Observational Study
Metabolic puzzle: Exploring liver fibrosis differences in Asian metabolic-associated fatty liver disease subtypes

World J Hepatol
16(1):54-64.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.54
Abstract (535)
|
Core Tip (539)
|
Article Highlights (626)
|
Full Article (HTML) (1853)
|
Figures (1-3) (406)
|
Tables (1-2) (369)
|
Full Article (PDF)-1874K (113)
|
Full Article with Cover (PDF)-12619K (105)
|
Full Article (XML)-114K (67)
|
Audio-386K (11)
|
Peer-Review Report-233K (85)
|
Answering Reviewers-161K (75)
|
Received: 10/02/2023
|
Revised: 10/22/2023
|
Accepted: 12/18/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (7071)
|
Similar Articles (14)
|
Timeline of Article Publication (4)
|
Authors Evaluation (2)
|
Article Quality Tracking (0)
|
Reader Comments (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Basic Study
Subcellular distribution of prohibitin 1 in rat liver during liver regeneration and its cellular implication

World J Hepatol
16(1):65-74.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.65
Abstract (464)
|
Core Tip (458)
|
Article Highlights (523)
|
Full Article (HTML) (1309)
|
Figures (1-4) (331)
|
Full Article (PDF)-5746K (111)
|
Full Article with Cover (PDF)-16492K (93)
|
Full Article (XML)-96K (74)
|
Audio-3997K (6)
|
Peer-Review Report-192K (65)
|
Answering Reviewers-146K (69)
|
Received: 09/30/2023
|
Revised: 11/03/2023
|
Accepted: 11/28/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (4735)
|
Similar Articles (41)
|
Timeline of Article Publication (1)
|
Authors Evaluation (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Rifaximin on epigenetics and autophagy in animal model of hepatocellular carcinoma secondary to metabolic-dysfunction associated steatotic liver disease

World J Hepatol
16(1):75-90.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.75
Abstract (513)
|
Core Tip (499)
|
Article Highlights (526)
|
Full Article (HTML) (2282)
|
Figures (1-4) (329)
|
Tables (1-5) (350)
|
Full Article (PDF)-6006K (146)
|
Full Article with Cover (PDF)-16750K (108)
|
Full Article (XML)-200K (72)
|
Audio-376K (3)
|
Peer-Review Report-182K (80)
|
Answering Reviewers-60K (81)
|
Supplementary Material-355K (84)
|
Received: 11/03/2023
|
Revised: 12/11/2023
|
Accepted: 01/02/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (7682)
|
Similar Articles (1849)
|
Timeline of Article Publication (3)
|
Authors Evaluation (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Meta-Analysis
Sorafenib plus transarterial chemoembolization vs sorafenib alone for patients with advanced hepatocellular carcinoma: A systematic review and meta-analysis

World J Hepatol
16(1):91-102.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.91
Abstract (468)
|
Core Tip (533)
|
Article Highlights (538)
|
Full Article (HTML) (1520)
|
Figures (1-4) (345)
|
Tables (1-4) (346)
|
Full Article (PDF)-5941K (113)
|
Full Article with Cover (PDF)-16687K (99)
|
Full Article (XML)-115K (69)
|
Audio-187K (9)
|
Peer-Review Report-215K (63)
|
Answering Reviewers-37K (78)
|
Received: 10/20/2023
|
Revised: 11/21/2023
|
Accepted: 12/12/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (6250)
|
Similar Articles (2455)
|
Timeline of Article Publication (3)
|
Authors Evaluation (5)
|
Article Quality Tracking (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Case Report
World J Hepatol
16(1):103-108.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.103
Abstract (503)
|
Core Tip (495)
|
Full Article (HTML) (1221)
|
Figures (1-1) (416)
|
Full Article (PDF)-5068K (107)
|
Full Article with Cover (PDF)-15813K (94)
|
Full Article (XML)-63K (63)
|
Audio-811K (3)
|
Peer-Review Report-266K (77)
|
Answering Reviewers-225K (78)
|
Received: 08/25/2023
|
Revised: 10/24/2023
|
Accepted: 12/12/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (4999)
|
Similar Articles (4211)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Letter to the Editor
Review on article of effects of tenofovir alafenamide and entecavir in chronic hepatitis B virus patients

World J Hepatol
16(1):109-111.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.109
Abstract (492)
|
Core Tip (500)
|
Full Article (HTML) (1245)
|
Full Article (PDF)-325K (100)
|
Full Article with Cover (PDF)-11079K (82)
|
Full Article (XML)-24K (76)
|
Audio-243K (1)
|
Peer-Review Report-215K (55)
|
Answering Reviewers-19K (56)
|
Received: 10/30/2023
|
Revised: 12/04/2023
|
Accepted: 01/12/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (3542)
|
Similar Articles (393)
|
Timeline of Article Publication (5)
|
Authors Evaluation (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open